C&EN Monthly - July 2023
Want more breaking chemistry news? Get the latest news distilled to your inbox?every week.?Subscribe now to our weekly email newsletter
Here are some of the top articles from?cen.acs.org?that have been creating a reaction:
C&EN’s Global Top 50 chemical firms for 2023. Despite headwinds like the war in Europe, high inflation, and the lingering effects of the COVID-19 pandemic, the US chemical industry made it out of 2022 in relatively good shape.
Chemist who survived thallium poisoning speaks out. A chemist wants to help raise awareness of the symptoms of thallium poisoning so that future victims won’t suffer an equally long delay until diagnosis and will have a better chance of identifying their poisoners.
领英推荐
Alzheimer’s drug donanemab slows cognitive decline, study confirms. Eli Lilly and Company have unveiled the full clinical results for its Alzheimer’s drug candidate, a monoclonal antibody called donanemab. The data show that donanemab staves off disease progression among people with early-stage Alzheimer’s.
US EPA sets guardrails for new PFAS. The US Environmental Protection Agency wants to ensure that all new per- and polyfluoroalkyl substances (PFAS) that enter the market are safe and won’t pollute the environment. Under a framework announced June 29, the agency plans to require toxicity testing for new PFAS that are likely to enter the environment.
Scientists are engineering asphalt that is safer for humans and the environment. Having defined links to human health, some researchers believe that making the next generation of asphalt will be a balancing act between mitigating carbon footprint, enhancing durability, and limiting adverse health outcomes for people paving and living near the roads.
Want more C&EN breaking news articles? Is once a month on LinkedIn not enough??Subscribe now to our weekly email newsletter?and get a first look at the latest and most comprehensive overview of the world of chemistry, distilled to your inbox every week.